International Stem Cell Corporation - Product Pipeline Review - 2015


#359855

23pages

Global Markets Direct

$ 1500

In Stock

International Stem Cell Corporation - Product Pipeline Review - 2015

Summary

Global Markets Directs, International Stem Cell Corporation - Product Pipeline Review - 2015, provides an overview of the International Stem Cell Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of International Stem Cell Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of International Stem Cell Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of International Stem Cell Corporations human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the International Stem Cell Corporations pipeline products

Reasons to buy

- Evaluate International Stem Cell Corporations strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of International Stem Cell Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the International Stem Cell Corporations R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of International Stem Cell Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of International Stem Cell Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of International Stem Cell Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
International Stem Cell Corporation Snapshot 4
International Stem Cell Corporation Overview 4
Key Information 4
Key Facts 4
International Stem Cell Corporation - Research and Development Overview 5
Key Therapeutic Areas 5
International Stem Cell Corporation - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
International Stem Cell Corporation - Pipeline Products Glance 9
International Stem Cell Corporation - Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
International Stem Cell Corporation - Early Stage Pipeline Products 10
Preclinical Products/Combination Treatment Modalities 10
International Stem Cell Corporation - Drug Profiles 11
ISC-hpNSC 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
CytoCor 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Stem Cell Therapy for Age Related Macular Degeneration and Retinitis Pigmentosa 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Stem Cell Therapy for Alpha-Antitrypsin Deficiency and Crigler-Najjar Syndrome 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
International Stem Cell Corporation - Pipeline Analysis 17
International Stem Cell Corporation - Pipeline Products by Molecule Type 17
International Stem Cell Corporation - Recent Pipeline Updates 18
International Stem Cell Corporation - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 22
Disclaimer 23

List of Tables
International Stem Cell Corporation, Key Information 4
International Stem Cell Corporation, Key Facts 4
International Stem Cell Corporation - Pipeline by Indication, 2015 6
International Stem Cell Corporation - Pipeline by Stage of Development, 2015 7
International Stem Cell Corporation - Monotherapy Products in Pipeline, 2015 8
International Stem Cell Corporation - Phase I, 2015 9
International Stem Cell Corporation - Preclinical, 2015 10
International Stem Cell Corporation - Pipeline by Molecule Type, 2015 17
International Stem Cell Corporation - Recent Pipeline Updates, 2015 18
International Stem Cell Corporation, Other Locations 21
International Stem Cell Corporation, Subsidiaries 21

List of Figures
International Stem Cell Corporation - Pipeline by Top 10 Indication, 2015 6
International Stem Cell Corporation - Pipeline by Stage of Development, 2015 7
International Stem Cell Corporation - Monotherapy Products in Pipeline, 2015 8
International Stem Cell Corporation - Pipeline by Top 10 Molecule Type, 2015 17

NA

NA